Remote ischemic preconditioning to prevent early worsening after small deep (perforating artery) ischemic stroke
Official title: Effect of Remote Ischemic Preconditioning on Early Neurological Deterioration in Acute Perforating Artery Infarction (RIC-END): A Randomised Multicentre Trial
Run by Jinling Hospital, China · NCT07237542 · Data updated 2026-11-12
This trial will test whether brief, repeated arm blood-pressure cuff inflations (remote ischemic preconditioning) can prevent early neurological worsening in adults who have had a small deep perforating artery ischemic stroke within 48 hours.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 910 (estimated) |
| Sponsor | Jinling Hospital, China Academic / other |
| Locations | 1 site (Nanjing, Jiangsu) |
| Status | Recruiting |
| Started | December 11, 2025 |
| Main results expected | November 20, 2027 |
| Study ends | November 20, 2027 |
| Registry record updated | February 3, 2026 |
| Trial ID | NCT07237542 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with acute perforating artery infarction within 48 hours, NIHSS ≤5, a single DWI lesion meeting the size/location criteria and parent artery stenosis <70%, who have not received thrombolysis or endovascular therapy, are the intended participants.
✕Probably not a fit
Patients with large cortical strokes, intracranial hemorrhage, secondary stroke causes, prior reperfusion therapy, severe deficits outside the inclusion criteria, or presentation beyond 48 hours are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, randomized, double-blind, multicenter, parallel-controlled, group-sequential trial comparing remote ischemic preconditioning (RIC) to a sham procedure in a 1:1 allocation. Adults with acute perforating artery infarction within 48 hours, low NIHSS scores, and a single small DWI-confirmed lesion are enrolled and treated with repeated brief limb ischemia or sham. The primary focus is on preventing early neurological deterioration (an increase of ≥2 points on the NIHSS within 7 days) with monitoring of safety and clinical outcomes. The trial aims to provide rigorous evidence on whether RIC reduces early worsening and improves short-term neurological status in this specific stroke subtype.
Why it matters
Potential benefit: If successful, RIC could reduce early neurological deterioration and lower short-term disability after small deep perforating artery strokes.
How similar studies have gone: Small physiological and pilot clinical studies have suggested RIC can protect ischemic brain tissue, but large randomized trials specifically in acute perforating artery infarction are lacking.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 18 years or older; 2. Diagnosed with acute ischemic stroke; 3. Clinical symptoms consistent with perforating artery infarction (NIHSS score ≤5, with consciousness item 1a ≤1); 4. Time from onset to randomization within 48 hours; 5. Diffusion-weighted imaging (DWI) showing a single infarct in the perforating artery territory with a maximum diameter ≤30 mm, meeting at least one of the following: (1) Diameter ≤15 mm and involving two or more axial slices; (2) Maximum diameter ≥15 mm; (3) Connected to the ventral surface of the pons but not crossing the midline; 6) Stenosis of parent artery \<70%; 7) Signed informed consent obtained from the patient or their legally authorized representative. Exclusion Criteria: 1. Received intravenous thrombolysis or endovascular treatment prior to randomization; 2. Secondary stroke caused by brain tumor, traumatic brain injury, hematologic disorders, or other conditions; 3. History of intracranial hemorrhage; 4. Presence of RIC contraindications, such as severe upper limb soft tissue injury, fracture, subclavian artery stenosis, or peripheral vascular disease; 5. Uncontrolled severe hypertension (systolic blood pressure \[BP\] ≥180 mmHg or diastolic BP ≥110 mmHg); 6. Severe hepatic or renal dysfunction (Alanine Aminotransferase or Aspartate Aminotransferase \> 3 × upper limit of normal; creatine kinase \>3 × upper limit of normal; estimated Glomerular Filtration Rate \< 30 mL / min / 1.73 m²); 7. Patients with thrombocytopenic purpura, coagulation disorders, or active visceral bleeding; 8. Patients in the acute phase of fundus hemorrhage; 9. History of severe aphasia or psychiatric disorders affecting clinical assessment; 10. Life expectancy \<90 days; 11. Pregnancy; 12. Inability to comply with follow-up; 13. Participation in other clinical trials.
Where it's running
-
Jinling Hospital, Medical School of Nanjing University, Nanjing
Nanjing, Jiangsu, China Recruiting
Study contacts
- Study coordinator: Wusheng Zhu, PhD
- Email: wusheng.zhu@nju.edu.cn
- Phone: +86 2584801861
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Remote ischemic conditioning for post-stroke insomnia
A 136-person, randomized study will test whether a non-invasive arm-cuff procedure done twice daily for 90 days can improve sleep after a first ischemic stroke in adults 18–80.
-
Ear-based nerve stimulation to help sleep after a stroke
A device that delivers vagal nerve stimulation through the ear is tested to see if it helps stroke patients in rehab sleep better.
-
Theta Burst Stimulation to Help Stroke Recovery (Upper and Lower Limbs)
This trial tests whether applying theta burst stimulation to the motor cortex, in combination with standard rehabilitation, helps people over 45 who recently had a first ischemic stroke recover arm and leg movement.
-
Preventing another ischemic stroke with a smart bracelet and app
This study tests whether a digital prevention program using a wearable and a mobile app can help people who recently had an ischemic stroke reduce the chance of another stroke and improve risk-factor control.
-
Photon-counting CT to check intracranial stents
This study tests whether ultra-high-resolution photon-counting CT can reliably visualize intracranial stents and detect in-stent restenosis during follow-up of patients with prior stents.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.